Regeneron Pharmaceuticals, Inc. REGN
973.36 USD +12.10 (+1.26%)
At closeNov 3, 2026, 4:42 PM EST
973.36 0.00 0.00%
After hours · Nov 3, 4:42 PM ET
953.00 Day range 975.49
591.52 52-week range 975.49
- YTD
- +26.10%
- 1 year
- +51.55%
Analyst view
Consensus: buy
Buy
Price target (mean) 976.44 +0.3% upside
Now 973.36
- Target (low)
- 812.00
- Target (mean)
- 976.44
- Target (high)
- 1,175.00
Ratings (0m) 28 19 buy · 9 hold · 0 sell
- Strong buy4
- Buy15
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 27
- 3 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 25.30 | 17.70 – 30.44 | 11.44 | +121.1% | 5.85B | +50.6% | 22 |
| Next quarter | 15.89 | 12.90 – 18.80 | 9.47 | +67.8% | 4.60B | +27.5% | 9 |
| Current year | 68.68 | 61.35 – 74.53 | 44.31 | +55.0% | 17.60B | +22.7% | 24 |
| Next year | 61.85 | 52.17 – 73.76 | 59.22 | +4.4% | 20.10B | +14.2% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Nov 2, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Nov 2, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | Truist Securities | Maintained | Buy | Buy |
| Nov 2, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Nov 2, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 2, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Nov 2, 2026 | Baird | Maintained | Neutral | Neutral |
| Nov 2, 2026 | B of A Securities | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 28, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 19, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 15, 2026 | UBS | Upgrade | Neutral | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Jefferies | Maintained | Buy | Buy |
| Oct 1, 2026 | Argus Research | Upgrade | Hold | Buy |
| Sep 29, 2026 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Aug 17, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 31, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
